Estradiol vs. Bijuve
See how Estradiol and Bijuve compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Estradiol treats menopause symptoms plus several other hormone-related conditions, while Bijuve is FDA-approved only for moderate to severe hot flashes in women with a uterus.
Bijuve combines estradiol and progesterone in one capsule, so women with a uterus do not need a separate progestin pill the way they might with estrogen-only estradiol.
Both carry boxed warnings for cardiovascular disease, breast cancer, dementia, and endometrial cancer risk, so either choice calls for a conversation with a doctor about personal risk factors.
Estradiol vs. Bijuve Drug Summary
Estradiol
Estradiol is a steroidal estrogen used for hormone replacement therapy. It treats moderate to severe hot flashes, vaginal atrophy, and low estrogen states, and is also used to prevent osteoporosis and to treat certain hormone-sensitive cancers. It comes in oral, transdermal, vaginal, and injectable forms, with the oral tablet taken once to several times a day depending on the indication.
Bijuve
Bijuve is a combination capsule containing bioidentical estradiol and micronized progesterone. It treats moderate to severe hot flashes from menopause in women who still have a uterus, with the progesterone included to protect the uterine lining. It is taken as one capsule by mouth once daily.
Estradiol vs. Bijuve Side Effects
Estradiol
Bijuve
Estradiol vs. Bijuve Dosage
Estradiol
Bijuve
| STAGE | DOSE | WHEN |
| Starting dose | 0.5 mg once daily | At the start |
| Maximum dose | 10 mg three times daily | If needed |
| Dose changes | 4 increases | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 0.5 mg/100 mg once daily | At the start |
| Maximum dose | 1 mg/100 mg once daily | If needed |
| Dose changes | 1 increase | As tolerated |
Estradiol
| STAGE | DOSE | WHEN |
| Starting dose | 0.5 mg once daily | At the start |
| Maximum dose | 10 mg three times daily | If needed |
| Dose changes | 4 increases | As tolerated |
Bijuve
| STAGE | DOSE | WHEN |
| Starting dose | 0.5 mg/100 mg once daily | At the start |
| Maximum dose | 1 mg/100 mg once daily | If needed |
| Dose changes | 1 increase | As tolerated |
Estradiol vs. Bijuve Indications
Estradiol
Estradiol has one of the broadest approved use lists of any estrogen product, covering hot flashes, vaginal atrophy, low estrogen from ovarian failure, osteoporosis prevention, and certain hormone-sensitive cancers. Its multiple forms, oral, transdermal, and vaginal, let dose and delivery match the specific indication.
Moderate to severe hot flashes and night sweats
Vaginal dryness and vulvar or vaginal atrophy
Low estrogen from ovarian failure or hypogonadism
Osteoporosis prevention after menopause
Bijuve
Bijuve is approved for one specific use: moderate to severe hot flashes from menopause in women who still have a uterus. The added progesterone protects the uterine lining, but this also means Bijuve cannot be prescribed for women without a uterus, unlike estrogen-only estradiol.
Moderate to severe hot flashes from menopause
Built-in progesterone protects the uterine lining
Approved only for women who still have a uterus
No need for a separate progestin pill
Estradiol vs. Bijuve Pros and Cons
Estradiol
Estradiol's long history and wide range of forms give prescribers flexibility to match dose and delivery to each patient's needs. It has been on the market since 1975, so its safety profile is very well studied, though picking the right formulation and strength can take some trial and error.
Pros
Available in many forms: oral tablet, patch, gel, spray, vaginal cream/ring, and injection
Longest track record of any FDA-approved estrogen, dating to 1975
Estrogen dose can be adjusted independently of any added progestogen
Cons
Needs a separate progestogen prescription for women with a uterus, adding a second pill
So many forms and strengths exist that choosing the right one can be confusing
Trial data show higher rates of respiratory-type effects like nasopharyngitis and sinusitis
Bijuve
Bijuve's single-capsule design simplifies dosing for women who need both estrogen and a progestogen. It is newer to the market than estradiol, so it carries a narrower approved use and less long-term real-world experience, but it avoids the need for a second prescription.
Pros
Combines estradiol and progesterone in one daily capsule, so no separate progestin pill is needed
Uses bioidentical micronized progesterone instead of a synthetic progestin
Only two dose strengths, making titration decisions simpler
Cons
FDA-approved for only one use, hot flashes, a narrower label than estradiol's
Not an option for women without a uterus, unlike estrogen-only estradiol products
Less long-term safety data, approved in 2018 versus 1975 for estradiol
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.